UA74045C2 - Суспензия, содержащая фибриноген, тромбин и спирт, способ приготовления суспензии, способ нанесения указанной суспензии на носитель, способ сушки нанесенного покрытия, коллагеновая губка с нанесенным покрытием фибриногена и тромбина, применение коллагеновой губки с нанесенным покрытием для склеивания и соединения тканей и гемостаза - Google Patents
Суспензия, содержащая фибриноген, тромбин и спирт, способ приготовления суспензии, способ нанесения указанной суспензии на носитель, способ сушки нанесенного покрытия, коллагеновая губка с нанесенным покрытием фибриногена и тромбина, применение коллагеновой губки с нанесенным покрытием для склеивания и соединения тканей и гемостаза Download PDFInfo
- Publication number
- UA74045C2 UA74045C2 UA2003087940A UA2003087940A UA74045C2 UA 74045 C2 UA74045 C2 UA 74045C2 UA 2003087940 A UA2003087940 A UA 2003087940A UA 2003087940 A UA2003087940 A UA 2003087940A UA 74045 C2 UA74045 C2 UA 74045C2
- Authority
- UA
- Ukraine
- Prior art keywords
- suspension
- thrombin
- fibrinogen
- carrier
- collagen
- Prior art date
Links
- 239000000725 suspension Substances 0.000 title claims abstract description 177
- 239000000515 collagen sponge Substances 0.000 title claims abstract description 137
- 238000000576 coating method Methods 0.000 title claims abstract description 125
- 239000011248 coating agent Substances 0.000 title claims abstract description 121
- 108090000190 Thrombin Proteins 0.000 title claims abstract description 118
- 238000000034 method Methods 0.000 title claims abstract description 118
- 229960004072 thrombin Drugs 0.000 title claims abstract description 118
- 108010049003 Fibrinogen Proteins 0.000 title claims abstract description 117
- 102000008946 Fibrinogen Human genes 0.000 title claims abstract description 117
- 229940012952 fibrinogen Drugs 0.000 title claims abstract description 117
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 113
- 238000001035 drying Methods 0.000 title claims abstract description 40
- 238000004026 adhesive bonding Methods 0.000 title claims abstract description 7
- 230000023597 hemostasis Effects 0.000 title claims abstract description 6
- 238000002360 preparation method Methods 0.000 title claims description 36
- 238000007789 sealing Methods 0.000 title abstract description 3
- 239000000203 mixture Substances 0.000 claims abstract description 128
- 108010035532 Collagen Proteins 0.000 claims abstract description 76
- 102000008186 Collagen Human genes 0.000 claims abstract description 76
- 229920001436 collagen Polymers 0.000 claims abstract description 76
- 239000002245 particle Substances 0.000 claims abstract description 34
- 238000002156 mixing Methods 0.000 claims abstract description 28
- 108010039627 Aprotinin Proteins 0.000 claims abstract description 16
- 229960004405 aprotinin Drugs 0.000 claims abstract description 16
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 claims abstract description 16
- 241000283690 Bos taurus Species 0.000 claims abstract description 13
- 235000019441 ethanol Nutrition 0.000 claims description 72
- 239000000512 collagen gel Substances 0.000 claims description 33
- 239000006260 foam Substances 0.000 claims description 32
- 238000012360 testing method Methods 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 14
- 229960003766 thrombin (human) Drugs 0.000 claims description 13
- 238000000926 separation method Methods 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 11
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 238000005299 abrasion Methods 0.000 claims description 8
- 238000000265 homogenisation Methods 0.000 claims description 8
- 239000012298 atmosphere Substances 0.000 claims description 6
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 230000002906 microbiologic effect Effects 0.000 claims description 6
- 108010088751 Albumins Proteins 0.000 claims description 4
- 102000009027 Albumins Human genes 0.000 claims description 4
- 229910001385 heavy metal Inorganic materials 0.000 claims description 3
- 230000005484 gravity Effects 0.000 claims description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 2
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 abstract description 8
- 241000282414 Homo sapiens Species 0.000 abstract description 5
- 239000003570 air Substances 0.000 description 33
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 22
- 239000000523 sample Substances 0.000 description 21
- 210000002435 tendon Anatomy 0.000 description 17
- 230000008021 deposition Effects 0.000 description 16
- 229940106780 human fibrinogen Drugs 0.000 description 15
- 206010052428 Wound Diseases 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 11
- 229960002477 riboflavin Drugs 0.000 description 11
- 235000019192 riboflavin Nutrition 0.000 description 11
- 239000002151 riboflavin Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 108010073385 Fibrin Proteins 0.000 description 10
- 102000009123 Fibrin Human genes 0.000 description 10
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 10
- 229950003499 fibrin Drugs 0.000 description 10
- 239000003292 glue Substances 0.000 description 9
- 239000004816 latex Substances 0.000 description 9
- 229920000126 latex Polymers 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 230000000740 bleeding effect Effects 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 229910000831 Steel Inorganic materials 0.000 description 7
- 238000001839 endoscopy Methods 0.000 description 7
- 238000005194 fractionation Methods 0.000 description 7
- 239000010959 steel Substances 0.000 description 7
- 238000001291 vacuum drying Methods 0.000 description 7
- 239000008215 water for injection Substances 0.000 description 7
- 238000001816 cooling Methods 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 4
- 238000002674 endoscopic surgery Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000002439 hemostatic effect Effects 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 210000001724 microfibril Anatomy 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 241000283073 Equus caballus Species 0.000 description 2
- 108010077465 Tropocollagen Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 210000000476 body water Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000006101 laboratory sample Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000002893 slag Substances 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 108010080865 Factor XII Proteins 0.000 description 1
- 102000000429 Factor XII Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920002201 Oxidized cellulose Polymers 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000013130 cardiovascular surgery Methods 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- RKTYLMNFRDHKIL-UHFFFAOYSA-N copper;5,10,15,20-tetraphenylporphyrin-22,24-diide Chemical compound [Cu+2].C1=CC(C(=C2C=CC([N-]2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3[N-]2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 RKTYLMNFRDHKIL-UHFFFAOYSA-N 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- -1 for example Chemical compound 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940107304 oxidized cellulose Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000007847 structural defect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Суспензию фибриногена, тромбина, спирта, которая факультативно может содержать и апротинин, получают смешиванием фибриногена в спирте с тромбином в спирте. Суспензия содержит частицы фибриногена и тромбина со средним диаметром по Folk Ward в пределах 25-100 мкм. В качестве тромбина может использоваться человеческий, бычий или рекомбинантный тромбин. В качестве фибриногена может использоваться человеческий или рекомбинантный фибриноген. Описан способ нанесения указанной суспензии на носитель, например коллагеновую губку, и способ сушки нанесенного покрытия. Коллагеновый носитель с нанесенным покрытием можно применять как готовую к применению абсорбируемую композицию для склеивания и соединения тканей и гемостаза.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200100135 | 2001-01-25 | ||
| PCT/IB2002/001454 WO2002058750A2 (en) | 2001-01-25 | 2002-01-25 | A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA74045C2 true UA74045C2 (ru) | 2005-10-17 |
Family
ID=34560110
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2003087940A UA74045C2 (ru) | 2001-01-25 | 2002-01-25 | Суспензия, содержащая фибриноген, тромбин и спирт, способ приготовления суспензии, способ нанесения указанной суспензии на носитель, способ сушки нанесенного покрытия, коллагеновая губка с нанесенным покрытием фибриногена и тромбина, применение коллагеновой губки с нанесенным покрытием для склеивания и соединения тканей и гемостаза |
| UA2003087941A UA74046C2 (en) | 2001-01-25 | 2002-01-25 | Solid composition containing solid fibrinogen and solid thrombin which is useful for tissue gluing, tissue sealing and bleeding arrest, method for gluing and sealing tissues, method for bleeding arrest |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2003087941A UA74046C2 (en) | 2001-01-25 | 2002-01-25 | Solid composition containing solid fibrinogen and solid thrombin which is useful for tissue gluing, tissue sealing and bleeding arrest, method for gluing and sealing tissues, method for bleeding arrest |
Country Status (4)
| Country | Link |
|---|---|
| EC (1) | ECSP034747A (ru) |
| UA (2) | UA74045C2 (ru) |
| UY (1) | UY27139A1 (ru) |
| ZA (3) | ZA200305591B (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112891610A (zh) * | 2021-01-25 | 2021-06-04 | 上海利康瑞生物工程有限公司 | 猪源纤维蛋白-静电纺丝纳米纤维抗菌止血贴剂及制备方法 |
-
2002
- 2002-01-25 UA UA2003087940A patent/UA74045C2/ru unknown
- 2002-01-25 UA UA2003087941A patent/UA74046C2/xx unknown
- 2002-01-25 UY UY27139A patent/UY27139A1/es not_active Application Discontinuation
-
2003
- 2003-07-18 ZA ZA200305591A patent/ZA200305591B/en unknown
- 2003-07-18 ZA ZA200305588A patent/ZA200305588B/en unknown
- 2003-07-18 ZA ZA200305592A patent/ZA200305592B/en unknown
- 2003-08-25 EC EC2003004747A patent/ECSP034747A/es unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112891610A (zh) * | 2021-01-25 | 2021-06-04 | 上海利康瑞生物工程有限公司 | 猪源纤维蛋白-静电纺丝纳米纤维抗菌止血贴剂及制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200305588B (en) | 2004-10-18 |
| UY27139A1 (es) | 2002-08-30 |
| ZA200305592B (en) | 2004-10-18 |
| UA74046C2 (en) | 2005-10-17 |
| ZA200305591B (en) | 2004-10-18 |
| ECSP034747A (es) | 2004-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA006686B1 (ru) | Суспензия, содержащая фибриноген, тромбин и спирт, способ её получения, способ нанесения покрытия, способ сушки покрытия и коллагеновая губка с покрытием | |
| US20050214277A1 (en) | Suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge | |
| AU2004206150B2 (en) | Hemostatic materials | |
| AU2002307809A1 (en) | A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same | |
| US5989215A (en) | Fibrin delivery device and method for forming fibrin on a surface | |
| US6461325B1 (en) | Fibrin delivery device and method for forming fibrin on a surface | |
| US9302026B2 (en) | Method for improved fibrin sealing | |
| UA74045C2 (ru) | Суспензия, содержащая фибриноген, тромбин и спирт, способ приготовления суспензии, способ нанесения указанной суспензии на носитель, способ сушки нанесенного покрытия, коллагеновая губка с нанесенным покрытием фибриногена и тромбина, применение коллагеновой губки с нанесенным покрытием для склеивания и соединения тканей и гемостаза | |
| RU2063175C1 (ru) | Способ остановки кровотечения | |
| WO1999010019A2 (en) | Heterofunctional tissue engineering compositions | |
| CN120981258A (zh) | 用于密封组织中的渗漏的止血密封剂粉末 | |
| Jackson | Fibrin sealant as a hemostatic agent in vascular surgery |